FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/12/099139 [Registered on: 15/12/2025] Trial Registered Prospectively
Last Modified On: 13/12/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Homeopathy 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   A study comparing two homeopathy repertories to find the best remedy for managing tinea versicolor using a symptom severity score 
Scientific Title of Study   A Comparative Study To Assess The Effectiveness Of G H G Jahrs Repertory Of Skin Symptoms With Synthesis Repertory In Selecting The Similimum For The Management Of Tinea Versicolor Assessed By Tinea Versicolor Symptom Severity Score A Randomised Double Arm Double Blinded Control Trial 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr ganganapalli venkata anish 
Designation  PG Scholor 
Affiliation  JIMS Homoeopathic Medical College and Hospital 
Address  OPD no 8 Department of Repertory and Case taking JIMS Homoeopathic Medical College and Hospital Sriramnagar Muchintal Village Palamakula PO Shamshabad Mandal
Department of Repertory and Case taking JIMS Homoeopathic Medical College Sriramnagar Muchintal Village Palamakula PO Shamshabad Mandal
Hyderabad
TELANGANA
509325
India 
Phone  8500386718  
Fax  04023470444  
Email  anishbuddy143@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Vishal deshpande 
Designation  Professor  
Affiliation  JIMS Homoeopathic Medical College and Hospital 
Address  OPD no 8 Department of Repertory and Case taking JIMS Homoeopathic Medical College and Hospital Sriramnagar Muchintal Village Palamakula PO Shamshabad Mandal

Hyderabad
TELANGANA
509325
India 
Phone  9422638599  
Fax  04023470444  
Email  drvishalvd@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr ganganapalli venkata anish 
Designation  PG Scholor 
Affiliation  JIMS Homoeopathic Medical College and Hospital 
Address  OPD no 8 Department of Repertory and Case taking JIMS Homoeopathic Medical College and Hospital Sriramnagar Muchintal Village Palamakula PO Shamshabad Mandal

Hyderabad
TELANGANA
509325
India 
Phone  8500386718  
Fax  04023470444  
Email  anishbuddy143@gmail.com  
 
Source of Monetary or Material Support  
JIMS Homoeopathic Medical College and Hospital Sriramnagar Muchintal Village Palamakula PO Shamshabad Mandal Hyderabad 509325 Telangana India 
 
Primary Sponsor  
Name  JIMS Homoeopathic Medical College and Hospital 
Address  JIMS Homoeopathic Medical College and Hospital Sriramnagar Muchintal Village Palamakula PO Shamshabad Mandal Hyderabad 509325 Telangana India 
Type of Sponsor  Private medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr ganganapalli venkata anish  JIMS Homoeopathic Medical College and Hospital  JIMS Homoeopathic Medical College and Hospital Sriramnagar Muchintal Village Palamakula PO Shamshabad Mandal Hyderabad 509325 Telangana India
Hyderabad
TELANGANA 
08500386718
04023470444
anishbuddy143@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
JIMS Homoeopathic Medical College and Hospital  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: B360||Pityriasis versicolor,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Individualised homoeopathic medicine using jahrs repertory  Medicines will be prescribed based on the selected similimum from the assigned repertory with each dose consisting of 4 pills of size No 20 Potency selection and repetition of doses will be determined according to the patients susceptibility with treatment duration typically spanning 4 to 6 weeks involving initial daily or biweekly doses followed by spacing based on response until symptom resolution 
Comparator Agent  Individualised homoeopathic medicine using synthesis repertory  Medicines will be prescribed based on the selected similimum from the assigned repertory with each dose consisting of 4 pills of size No 20 Potency selection and repetition of doses will be determined according to the patients susceptibility with treatment duration typically spanning 4 to 6 weeks involving initial daily or biweekly doses followed by spacing based on response until symptom resolution. 
 
Inclusion Criteria  
Age From  20.00 Year(s)
Age To  65.00 Year(s)
Gender  Both 
Details  diagnosed with Tinea Versicolor according to ICD 11 criteria and KOH mount test
Adults aged 20-65 years diagnosed with tinea versicolor
No internal or topical antifungal treatment for at least four weeks prior to enrolment
Willingness to provide informed consent and adhere to study protocols.
 
 
ExclusionCriteria 
Details  Pregnant or breastfeeding women
Significant comorbidities affecting skin health
Patients with severe life threatening systemic illness and those who demands acute emergency interventions.
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Pre-numbered or coded identical Containers 
Blinding/Masking   Participant and Investigator Blinded 
Primary Outcome  
Outcome  TimePoints 
Expect to elicit significant comparative changes in Tinea Versicolor symptom Severity Score at baseline 3rd month and 6th month   Tinea versicolor severity score at Baseline 3rd month and 6th month 
 
Secondary Outcome  
Outcome  TimePoints 
NIL  NIL 
 
Target Sample Size   Total Sample Size="36"
Sample Size from India="36" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   15/01/2026 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="2"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   Tinea versicolor is a recurrent superficial fungal infection caused by malassezia species presenting with hypo or hyperpigmented scaly patches that significantly impact cosmetic appearance and quality of life conventional antifungal therapies often provide temporary relief with high relapse rates and persistent pigmentary changes complicating long term management homeopathy with its individualized approach offers a potential alternative yet comparative evidence on repertory based remedy selection remains limited this randomized double blind double arm control trial aims to evaluate the effectiveness of g h g jahrs repertory of skin symptoms versus the synthesis repertory in selecting the similimum for patients diagnosed with tinea versicolor a total of 60 participants fulfilling icd-11 diagnostic criteria and positive koh findings will be enrolled and allocated into two groups each receiving individualized homeopathic treatment based on respective repertorization methods treatment outcomes will be assessed using the tinea versicolor symptom severity score at baseline and 6 months statistical analysis using the mann whitney u test will determine differences in clinical improvement between groups the study seeks to generate robust evidence on repertory efficacy enhance understanding of homeopathic dermatological practice and support the development of more precise repertory selection strategies for managing tinea versicolor. 
Close